We're THIS CLOSE to Covid-19 vaccines for younger children

We're THIS CLOSE to Covid-19 vaccines for younger children   The US Food and Drug Administration issued emergency use authorization last week for Pfizer's Covid-19 vaccine for children ages 5 to 11. This is the first Covid-19 vaccine authorized in the United States for younger children.   Pfizer says a clinical trial showed its vaccine provides more than 90% protection against symptomatic disease among children -- even at one-third the dose, and the company hopes the lower dose will reduce the risk of any side effects.   Remember, shots can't be administered just yet. The question is now with the US Centers for Disease Control and Prevention. The CDC's vaccine advisers, the Advisory Committee on Immunization Practices, is meeting toda to discuss whether to recommend use of the vaccine among US children ages 5 to 11. Then CDC Director Dr. Rochelle Walensky, will make the final decision on the use of the vaccine.   "While vaccinations may start later this week, the program will still be ramping up to its full strength, with millions more doses packed, shipped and delivered and thousands of additional sites coming online each day," White House Coronavirus Response Coordinator Jeff Zients said during a virtual White House briefing on Monday.